CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Issue
- Issue Number:2
SUMMARY
Percutaneous treatment of chronic total occlusions may result in dissection or perforation. A fiberoptic guidance system that visualizes lesion characteristics and incorporates a radiofrequency energy source to aid in crossing total occlusions was used to cross five superficial femoral artery lesions, and there were no observed complications.INTRODUCTION
Recent study of percutaneous intervention in chronic superficial femoral artery (SFA) occlusions indicates crossing the lesion is feasible in 68-100% of cases1-12 but that flow-limiting dissections and - Issue Number:2
The patient is a 83-year old male with an infrarenal abdominal aortic aneurysm (AAA) and right iliac aneurysm. Previously the patient underwent coil embolization of the proximal right hypogastric artery followed by stent grafting of the abdominal aortic aneurysm. The right limb of the stent graft ended in the proximal external iliac artery. At 1-month follow-up, a large type II endoleak via the inferior mesenteric artery was present. Repeat CT-scan completed at 3 months showed enlargement of the endoleak and a small amount of enlargement of the AAA. The patient underwent coil embolization of t
- Issue Number:2
Introduction
Thrombus is now accepted as playing a key role in patients with acute myocardial infarction (AMI), unstable angina, acute coronary syndromes (ACS), deep venous thrombosis (DVT), pulmonary embolus (PE), and acute limb ischemia (ALI). Angioscopic evidence of thrombus was noted in a significant percentage of patients presenting with ACS and AMI by White et al.1 and large acute and subacute thrombus burdens are often associated with ALI, DVT, and PE. Thrombus formation is a complex process. It culminates in a final common pathway, with the thrombin cleavage of fibri - Issue Number:2
The advent of endoluminal graft repair for abdominal aortic aneurysms has dramatically changed the therapeutic option for many patients. It is now well established that the devices can be safely inserted and short-term results have been excellent. Long-term outcome for many of these patients remains uncertain. The authors present a case report in which incomplete exclusion of the aneurysm with continued endoleak has resulted in aneurysm enlargement. As a result, the patient is not protected from continued expansion and the potential for eventual rupture. It is established in the literature tha
- Issue Number:2
A national and international thought leader in the field of vascular medicine, Dr. Jaff recently served as the Medical Director of the Vascular Ultrasound Core Laboratory at the Cardiovascular Research Foundation in Morristown, New Jersey. He has lectured extensively throughout the world, and has authored numerous publications in the field. Dr. Jaff currently serves on the Editorial Board for Catheterization and Cardiovascular Intervention, Journal of Endovascular Therapy, Journal of Invasive Cardiology, and Angiology. He is currently President of the Society for Vascular Medic
- Issue Number:2
Many physicians are exploring device use in the lower extremities, while techniques for successful and appropriate stenting are also being intensely discussed. Where does cryoplasty fit into the current picture?
Peripheral vascular disease, in general, is a relentless and proliferative process. With cryoplasty, whether it be in the fem-pop segment or below the knee, we are trying to achieve both better acute outcomes and long-term outcomes. What we're trying to accomplish is a minimization of the need for stent implants in the legs because they have their own set of problems and simu - Issue Number:2
Why do you think this board is of value to the field of endovascular medicine?
Right now, there aren’t enough experts in vascular medicine to care for the masses of patients who have systemic atherosclerosis. So many different specialists are involved in the care of these patients that it’s hard to know who really has expertise in the overall management of patients with vascular disease. The concept behind the creation of the American Board of Vascular Medicine is to set a standard level so that people who have really dedicated themselves to the management of these patients and to - Issue Number:2
Drug-eluting stents (DES) have revolutionized the treatment of obstructive coronary disease and expanding their applications to the periphery is inevitable. However, a better understanding of stent-associated restenosis in the periphery is needed.
1) The restenosis rate is very different in various vascular beds and clearly very high in infrainguinal vessels. The superficial femoral artery is probably the vascular bed that will be most in need of DES technology, given its long lesions and high restenosis rate.2) The restenosis process in the periphery appears to continue beyond t
- Issue Number:2
The patient is a 72-year-old woman who was transferred from a local area hospital for continued work up of PVD with ischemia of the third digit on the left foot. The patient had undergone attempted left lower extremity bypass. However, autogenous veins were found unsuitable to serve as conduit and the procedure was aborted. She was admitted to Yale-New Haven Hospital under the podiatric surgical service for a final attempt at limb salvage.
The patient has a significant past medical history: PVD, diabetes, coronary artery disease, hypertension, hypercholesterolemia, myocardial infarction, c
- Issue Number:2
Vascular Disease Management accepts original articles and case studies for publication. Please contact the managing editor, Rebecca Kapur, at VascularEditor@hotmail.com, or by phone at (800) 459-8657.
Manuscripts may be submitted at vasculareditor@hotmail.com in a Microsoft Word document file. Images should be provided in their original file formats, as “.jpg”, “.tif”, “.pdf” or “.eps” files. (Microsoft PowerPoint files are acceptable, but may not provide the highest image quality.)
Submitted manuscripts will undergo a double-blind peer review by at least on
Digital Supplements Using Advanced Technology to |
 Superior Mesenteric Artery Revascularization and |
Vascular Disease News Wire
- Thursday, December 11, 2008 - 16:23
- Monday, November 24, 2008 - 11:56
- Monday, October 6, 2008 - 10:02
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
 LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 Phone: (305) 604-1601 Toll Free: 1-877-563-9762 This activity is sponsored by the North American Center for Continuing Medical Education. |
 CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 This activity is supported by an educational grant from Bracco Diagnostics Inc. |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
